Human-cell study finds CBD partially reduced neuroinflammatory markers

A peer-reviewed Scientific Reports study found that 1 micromolar CBD partially reduced selected inflammatory markers in activated human microglia and neuron-like cell models. The result is preclinical, not evidence of patient benefit, but gives Oklahoma product and research teams a federally funded mechanistic signal to track.